The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

The Munich Gallbladder Lithotripsy Study: Results of the First 5 Years with 711 Patients

Michael Sackmann, MD; Juergen Pauletzki, MD; Tilman Sauerbruch, MD; Joseph Holl, MD; Gustav Schelling, MD; and Gustav Paumgartner, MD
[+] Article, Author, and Disclosure Information

Grant Support: By the Koerber Foundation.

Requests for Reprints: Michael Sackmann, MD, Department of Medicine II, Klinikum Grosshadern, University of Munich, P.O. Box 701260, 8000 Munich 70, Germany.

Current Author Addresses: Drs. Sackmann, Pauletzki, Sauerbruch, Holl, Schelling, and Paumgartner: Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich 70, Germany.

© 1991 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1991;114(4):290-296. doi:10.7326/0003-4819-114-4-290
Text Size: A A A

Objective: To evaluate the long-term results of three types of shock wave treatment in patients with radiolucent gallbladder stones.

Design: Cohort study.

Setting: Single-center trial.

Patients: Of 5824 patients with gallstones, 19% were eligible; 711 patients were treated.

Interventions: Patients received extracorporeal shock wave lithotripsy as well as adjuvant therapy with bile acids.

Results: Lithotripsy was done in three ways, using a water-tank lithotriptor (group A), a water-cushion lithotriptor at low energy levels (group B), and a water-cushion lithotriptor at high energy levels (group C). The rate of complete fragment clearance 9 to 12 months after lithotripsy was done differed significantly among the three groups: Among patients with single stones of 20 mm or less in diameter, the rate of fragment clearance for group A was 76%; for group B, it was 60%; and for group C, it was 83% (P = 0.03). Among patients with single stones of 21 to 30 mm, the rate of fragment clearance for group A was 63%; for group B, it was 32%; and for group C, it was 58% (P < 0.005). Among patients with two or three stones, the rate of fragment clearance for group A was 38%; for group B, it was 16%; and for group C, it was 46% (P = 0.01). Patients with fragments of 3 mm or less 24 hours after lithotripsy was done showed a higher probability of fragment disappearance than did those with larger fragments (P < 0.001). The clearance rate was higher in patients who were compliant than in those who were noncompliant with bile acid therapy (P < 0.001). Adverse effects included liver hematoma in 1 patient, biliary pain attacks in 253 patients (36%), mild biliary pancreatitis in 13 patients (2%), and cholestasis in 7 patients (1%). Elective cholecystectomy was done in 16 patients (2%), and endoscopic sphincterotomy was done in 4 patients (1%).

Conclusions: The rate of complete disappearance of stones after shock wave therapy depends on the size and the number of the initial stones, the diameter of the largest fragment, and the mode of shock wave treatment. Adjuvant therapy with bile acids appears to be important for complete fragment clearance.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.